Skip to main content
. 2016 Oct;13(10):1704–1711. doi: 10.1513/AnnalsATS.201602-142OC

Table 1.

Comparison of nodule documentation and follow-up among study patients

Characteristics   Documentation of Nodule
Follow-Up of Nodule
  All Patients (n = 344) Documentation (n = 181) No Documentation (n = 163) P Value* Follow-Up (n = 140) No Follow-Up (n = 204) P Value
Sex              
 Female 182 (53) 101 (56) 81 (50) 0.26 79 (56) 103 (50) 0.28
 Male 162 (47) 80 (44) 82 (50)   61 (44) 101 (50)  
Age, yr, mean ± SD 53.5 ± 16.4 58.0 ± 14.7 48.4 ± 16.7 <0.001 57.8 ± 12.9 50.5 ± 17.8 <0.001
Race and/or ethnicity              
 White, not Hispanic 135 (39) 80 (44) 55 (34) <0.001 63 (45) 72 (35) <0.001
 Black, not Hispanic 97 (28) 61 (34) 36 (22)   53 (38) 44 (22)  
 Other or not reported 112 (33) 40 (22) 72 (44)   24 (17) 88 (43)  
Preferred language              
 English 277 (81) 158 (87) 119 (73) 0.001 125 (89) 152 (75) 0.001
 Other 67 (19) 23 (13) 44 (27)   15 (11) 52 (25)  
Insurance              
 Uninsured 72 (21) 38 (21) 34 (21) 0.04 38 (27) 34 (17) 0.03
 Medicaid/Medicare 167 (49) 98 (54) 69 (42)   67 (48) 100 (49)  
 Private 105 (30) 45 (25) 60 (37)   35 (25) 70 (34)  
Smoking              
 Never 66 (19) 33 (18) 33 (20) <0.001 22 (16) 44 (21) 0.005
 Former 81 (24) 57 (32) 24 (15)   45 (32) 36 (18)  
 Current 76 (22) 45 (25) 31 (19)   34 (24) 42 (21)  
 Not assessed 121 (35) 46 (25) 75 (46)   39 (28) 82 (40)  
CT type              
 CT of chest with contrast 128 (37) 83 (46) 45 (28) <0.001 70 (50) 58 (28) <0.001
 CT angiogram (PE protocol) 76 (22) 32 (17) 44 (27)   21 (15) 55 (27)  
 CT of chest without contrast 71 (20) 45 (25) 26 (16)   36 (26) 35 (17)  
 CT of chest, abdomen, and pelvis with contrast 47 (14) 14 (8) 33 (20)   3 (2) 44 (22)  
 CT of chest, abdomen, and pelvis without contrast 6 (2) 1 (0.5) 5 (3)   2 (1) 4 (2)  
 High-resolution chest CT 10 (3) 5 (3) 5 (3)   7 (5) 3 (1.5)  
 Other 6 (2) 1 (0.5) 5 (3)   1 (1) 5 (2.5)  
Nodule size was reported 222 (65) 136 (75) 86 (53) <0.001 102 (73) 120 (59) 0.008
Nodule size, mm, median (IQR) 6.0 (4.0–9.9) 7.0 (4.2–11) 5.0 (3–8) <0.001 7.65 (5–12) 5 (3–8) <0.001
Nodule number              
 Single 168 (49) 79 (44) 89 (55) 0.04 68 (49) 100 (49) 0.9
 Multiple 176 (51) 102 (56) 74 (45)   72 (51) 104 (51)  
Radiologist’s description of nodule              
 Mass 14 (4) 11 (6) 3 (2) 0.002 11 (8) 3 (2) 0.002
 Nodule 180 (52) 106 (59) 74 (46) 0.002 81 (58) 99 (48)  
 Ground glass 15 (4) 8 (4) 7 (4)   6 (4) 9 (4)  
 Density 18 (5) 6 (3) 12 (7)   9 (6) 9 (4)  
 Nodular density 49 (14) 26 (14) 23 (14)   17 (12) 32 (16)  
 Granuloma 20 (6) 3 (2) 17 (11)   3 (2) 17 (8)  
 Opacity 24 (7) 9 (5) 15 (9)   4 (3) 20 (10)  
 Other 24 (7) 12 (7) 12 (7)   9 (6) 15 (7)  
Radiologist’s specialty              
 Not chest and body 151 (44) 79 (44) 72 (44) 0.92 57 (41) 94 (46) 0.32
 Chest and body 193 (56) 102 (56) 91 (56)   83 (59) 110 (54)  
Report location where nodule was mentioned              
 Findings and impression 291 (85) 174 (96) 117 (72) <0.001 132 (94) 159 (78) < 0.001
 Findings only 50 (14) 7 (4) 43 (26)   8 (6) 42 (21)  
 Impression only 3 (1) 0 3 (2)   0 3 (1)  
Radiologist’s report recommended follow-up 197 (57) 132 (73) 65 (40) <0.001 97 (69) 100 (49) <0.001
Fleischner statement included 27 (8) 16 (9) 11 (7) 0.47 9 (6) 18 (9) 0.42
Radiologist’s report mentioned communication of findings to ordering provider 20 (6) 10 (6) 10 (6) 0.81 8 (6) 12 (6) 0.95
Number of PCP visits in subsequent 2 yr, mean ± SD 1.91 ± 3.68 2.75 ± 4.34 0.98 ± 2.47 <0.001 2.73 ± 3.99 1.35 ± 3.35 <0.001
Death 34 (10) 24 (13) 10 (6) 0.03 15 (11) 19 (9.5) 0.71

Definition of abbreviations: CT = computed tomography; IQR = interquartile range; PCP = primary care provider; PE = pulmonary embolism.

Data are presented as number (percent) unless otherwise specified.

*

P value represents comparison of characteristics between group with documentation and group with no documentation.

P value represents comparison of characteristics between group with follow-up and group with no follow-up.